Romanian Journal of Pharmaceutical Practice (Sep 2020)

Ibuprofen in the current practice of the pharmacist in the community pharmacy

  • Paula Antonoaea,
  • Nicoleta Todoran,
  • Emőke Rédai,
  • Robert Alexandru Vlad,
  • Magdalena Bîrsan,
  • Aura Rusu,
  • Adriana Ciurba

DOI
https://doi.org/10.37897/RJPhP.2020.3.1
Journal volume & issue
Vol. 13, no. 3
pp. 115 – 120

Abstract

Read online

The pharmacist from the community pharmacy plays a key role in the case of patients who seek directly for pathologies related to pain. Being a health specialist, he has the ability to offer pharmaceutical healthcare for drugs that need a medical prescription and also for the ones that are registered as OTC’s. Ibuprofen (IBU) is a part of the drug group called nonsteroidal anti-inflammatory drugs (NSAIDs) being registered in Romania under 17 pharmaceutical formulation by the National Agency of Drugs and Medical Devices. Due to its pharmacological profile which consists of a low risk of gastrointestinal side effects, IBU is an OTC recommended and frequently prescribed for decreasing the low and moderate pain. World Health Organization (WHO) indicates IBU as a drug that can be used to babies aged over three months. Through this paper, we try to analyze the pharmacist’s vision from the community pharmacy in IBU recommendation. In this paper were mentioned some legal aspects that are linked to the pharmacist competences, and also its approach regarding IBU recommendation during pregnancy and breastfeeding and also to children and to a category of patients who have various associated pathologies.

Keywords